DE3125216C2 - N-(6-Fluor- oder Chlor-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten - Google Patents

N-(6-Fluor- oder Chlor-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten

Info

Publication number
DE3125216C2
DE3125216C2 DE3125216A DE3125216A DE3125216C2 DE 3125216 C2 DE3125216 C2 DE 3125216C2 DE 3125216 A DE3125216 A DE 3125216A DE 3125216 A DE3125216 A DE 3125216A DE 3125216 C2 DE3125216 C2 DE 3125216C2
Authority
DE
Germany
Prior art keywords
methyl
benzothiazine
oxo
dioxide
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3125216A
Other languages
German (de)
English (en)
Other versions
DE3125216A1 (de
Inventor
Hiroshi Kawazura
Takafumi Kitano
Hideya Kamakura Kanagawa Kobayashi
Mikio Mobara Chiba Kumakura
Haruki Yokohama Kanagawa Mori
Takuo Yokohama Kanagawa Nakano
Yutaka Okazaki
Shoichiro Ozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8645580A external-priority patent/JPS5714589A/ja
Priority claimed from JP56025002A external-priority patent/JPS57140785A/ja
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Publication of DE3125216A1 publication Critical patent/DE3125216A1/de
Application granted granted Critical
Publication of DE3125216C2 publication Critical patent/DE3125216C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3125216A 1980-06-27 1981-06-26 N-(6-Fluor- oder Chlor-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten Expired DE3125216C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8645580A JPS5714589A (en) 1980-06-27 1980-06-27 Benzothiazine derivative, its preparation and drug composition
JP56025002A JPS57140785A (en) 1981-02-24 1981-02-24 Benzothiazine derivative, its preparation, and pharmaceutical composition containing the same

Publications (2)

Publication Number Publication Date
DE3125216A1 DE3125216A1 (de) 1982-03-25
DE3125216C2 true DE3125216C2 (de) 1984-08-16

Family

ID=26362607

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3125216A Expired DE3125216C2 (de) 1980-06-27 1981-06-26 N-(6-Fluor- oder Chlor-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten

Country Status (6)

Country Link
CA (1) CA1177484A (enExample)
DE (1) DE3125216C2 (enExample)
FR (1) FR2485532A1 (enExample)
GB (1) GB2078738B (enExample)
IT (1) IT1211068B (enExample)
NL (1) NL186862C (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
GB1308533A (en) * 1969-06-02 1973-02-21 Pfizer Benzothiazine dioxides as anti-thombotic agents

Also Published As

Publication number Publication date
FR2485532B1 (enExample) 1984-02-03
CA1177484A (en) 1984-11-06
DE3125216A1 (de) 1982-03-25
IT1211068B (it) 1989-09-29
GB2078738A (en) 1982-01-13
NL186862B (nl) 1990-10-16
NL8103042A (nl) 1982-01-18
GB2078738B (en) 1983-11-30
IT8122548A0 (it) 1981-06-24
NL186862C (nl) 1991-03-18
FR2485532A1 (fr) 1981-12-31

Similar Documents

Publication Publication Date Title
DE3008056C2 (enExample)
DE3409801A1 (de) Thiazolidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3503435A1 (de) 6-substituierte furo-(3,4-c)-pyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2557497A1 (de) Neue tryptophanderivate mit erhoehter wirkung auf das zentralnervensystem
CH637385A5 (de) Verfahren zur herstellung von pyrimidin-derivaten und von deren pharmakologisch vertraeglichen salzen.
EP0629401A1 (de) Verwendung von 1,2,4-Dithia-zolium-Salzen als Chemotherapeutica insbesondere als TNF-Inhibitoren sowie neue 1,2,4-Dithiazolium-Salze
DE2634903C2 (de) Tetrahydrothieno-[3,2-c]-pyridin-Derivate und sie enthaltende Arzneimittel
AT391864B (de) Verfahren zur herstellung von neuen 5-pyrimidincarboxamiden und deren additionssalzen
DE3446371A1 (de) 5-pyrimidincarboxamide und 5-pyrimidinthiocarboxamide und ihre verwendung zur behandlung von leukaemie und tumoren
DE2414273B2 (de) N-Methyl-D-glucaminsalz von 2-(2'-Methyl-3'-trifluormethyl-anilin)-nicotinsäure, Verfahren zu seiner Herstellung und es enthaltende Arzneimittelzubereitung
DE2635961A1 (de) Therapeutisch wirksame verbindungen und verfahren zu ihrer herstellung
DE2059358A1 (de) Pyridon- und Thiopyridonderivate,die als entzuendungshemmende Mittel geeignet sind
DE3125216C2 (de) N-(6-Fluor- oder Chlor-2-pyridyl)-3,4-dihydro-2-methyl-4-oxo-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die diese enthalten
DE2945701A1 (de) S-triazinone und s-triazinthione, verfahren zu deren herstellung und diese verbindungen enthaltende therapeutische zubereitungen
DE2550959C3 (de) Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2818351A1 (de) Benzoesaeurederivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE2457309A1 (de) 2-phenylhydrazinothiazolin- beziehungsweise 2-phenylhydrazinothiazininderivate sowie ihre verwendung und verfahren zur herstellung derselben
DE2322486C2 (de) as-Triazino [5,6-c] chinolin und seine Salze, Verfahren zur Herstellung derselben sowie diese Verbindungen enthaltende Arzneimittel
DE3438244C2 (enExample)
DE3343550A1 (de) Triazinderivate
CH649289A5 (de) 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren.
DE3618724A1 (de) N-(3-(nitro)-chinol-4-yl)-carboxamidinamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1934392C3 (de) Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung
LU83497A1 (de) Amidderivate der p-isobutylphenylpropionsaeure,ihre herstellung und diese enthaltende arzneimittel
DE2737520A1 (de) Tetrahydropyridylderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee